Self-reported confusion is related to global and regional β-amyloid: data from the Women’s healthy ageing project
- 157 Downloads
Disease-modifying treatments for Alzheimer’s disease (AD) may require implementation during early stages of β-amyloid accumulation, well before patients have objective cognitive decline. In this study we aimed to assess the clinical value of subjective cognitive impairment (SCI) by examining the cross-sectional relationship between β-amyloid load and SCI. Cerebral β-amyloid and SCI was assessed in a cohort of 112 cognitively normal subjects. Subjective cognition was evaluated using specific questions on memory and cognition and the MAC-Q. Participants had cerebral β-amyloid load measured with 18F–Florbetaben Positron Emission Tomography (PET). No associations were found between measures of subjective memory impairment and cerebral β-amyloid. However, by self-reported confusion was predictive of a higher global β-amyloid burden (p = 0.002), after controlling for confounders. Regional analysis revealed significant associations of confusion with β-amyloid in the prefrontal region (p = 0.004), posterior cingulate and precuneus cortices (p = 0.004) and the lateral temporal lobes (p = 0.001) after controlling for confounders. An in vivo biomarker for AD pathology was associated with SCI by self-reported confusion on cross-sectional analysis. Whilst there has been a large body of research on SMC, our results indicate more research is needed to explore symptoms of confusion.
KeywordsAlzheimer’s disease Subjective cognitive impairment Subjective memory β-amyloid PET imaging Confusion
We would like to acknowledge the contribution of participants, team members, partners and their supporters who have given their time and patience for over 20 years to the university. A full list of all researchers contributing to the WHAP and membership of our Scientific Advisory Board is available at www.whap.unimelb.edu.au. Funding for the WHAP has been provided by the Australian National Health and Medical Research Council (NHMRC 1062133, 547600, 1032350), Bayer Healthcare, the Ramaciotti Foundation, the Brain Foundation, the Alzheimer’s Association of Australia, the Australian Menopausal Society, the Shepherd Foundation, the Scobie and Claire Mackinnon Trust, the Collier Trust Fund, the J.O. & J.R. Wicking Trust, the Mason Foundation and the Alzheimer’s Association (NIA320312). Inaugural funding was provided by VicHealth and the NHMRC.
Compliance with ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., & Phelps, C. H. (2011). The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia, 7, 270–279.CrossRefGoogle Scholar
- Han, J. H., Wilson, A., Vasilevskis, E. E., Shintani, A., Schnelle, J. F., Dittus, R. S., & Ely, E. W. (2013). Diagnosing delirium in older emergency department patients: validity and reliability of the delirium triage screen and the brief confusion assessment method. Annals of Emergency Medicine, 62(5), 457–465. doi: 10.1016/j.annemergmed.2013.05.003.CrossRefPubMedPubMedCentralGoogle Scholar
- Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008). Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. Journal of Neuroinflammation, 5, 37. doi: 10.1186/1742-2094-5-37.CrossRefPubMedPubMedCentralGoogle Scholar
- Merrill, D. A., Siddarth, P., Saito, N. Y., Ercoli, L. M., Burggren, A. C., Kepe, V., & Small, G. W. (2012). Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia. International Psychogeriatrics, 24, 1076–1084.CrossRefPubMedPubMedCentralGoogle Scholar
- Peres, K., Helmer, C., Amieva, H., Matharan, F., Carcaillon, L., Jacqmin-Gadda, H., & Dartigues, J. F. (2011). Gender differences in the prodromal signs of dementia: memory complaint and IADL-restriction. A prospective population-based cohort. Journal of Alzheimer's Disease, 27, 39–47.PubMedGoogle Scholar
- Perrotin, A., Mormino, E. C., Madison, C. M., Hayenga, A. O., & Jagust, W. J. (2012). Subjective cognition and amyloid deposition imaging: a Pittsburgh compound B positron emission tomography study in normal elderly individuals. Archives of Neurology, 69, 223–229.CrossRefPubMedPubMedCentralGoogle Scholar
- Pietrzak, R. H., Scott, J. C., Neumeister, A., Lim, Y. Y., Ames, D., Ellis, K. A., & Maruff, P. (2014). Anxiety symptoms, cerebral amyloid burden and memory decline in healthy older adults without dementia: 3-year prospective cohort study. British Journal of Psychiatry, 204, 400–401.CrossRefPubMedGoogle Scholar
- Szoeke, C. E., Robertson, J. S., Rowe, C. C., Yates, P., Campbell, K., Masters, C. L., & Desmond, P. (2013). The Women's healthy ageing project: fertile ground for investigation of healthy participants 'at risk' for dementia. International Review of nn, 25, 726–737.Google Scholar